Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.17% |
| 2 | Financials | 6.59% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 4.26% |
| 5 | Consumer Discretionary | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTI
2826
QT Imaging Holdings
QTI
$36.9M
| $5.23M | ﹤0.01% |
525,000
+275,000
| +110% | +$2.73M |
|
|
ABP
2827
DELISTED
Abpro Holdings
ABP
| $5.22M | ﹤0.01% |
+17,556
| New | +$5.22M |
|
|
ZWRK
2828
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
| $5.22M | ﹤0.01% |
533,862
+303,644
| +132% | +$2.96M |
|
|
RXRA
2829
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $5.22M | ﹤0.01% |
535,581
-5,251
| -1% | -$51K |
|
|
BLU
2830
DELISTED
BELLUS Health Inc.
BLU
| $5.21M | ﹤0.01% |
757,876
-3,083,130
| -80% | -$19.9M |
|
2831
Farmers & Merchants Bancorp
FMAO
$469M
| $5.21M | ﹤0.01% |
144,214
+43,241
| +43% | +$1.44M |
|
2832
Enbridge
ENB
$118B
| $5.21M | ﹤0.01% |
113,022
-570,967
| -83% | -$24.5M |
|
|
AUD
2833
DELISTED
Audacy, Inc.
AUD
| $5.21M | ﹤0.01% |
1,801,999
+1,268,139
| +238% | +$3.35M |
|
|
SSAA
2834
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $5.21M | ﹤0.01% |
530,597
-289,388
| -35% | -$2.82M |
|
2835
Allogene Therapeutics
ALLO
$635M
| $5.2M | ﹤0.01% |
571,206
+416,173
| +268% | +$4.33M |
|
2836
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $5.19M | ﹤0.01% |
230,097
-651,209
| -74% | -$15.1M |
|
2837
Artivion
AORT
$1.34B
| $5.18M | ﹤0.01% |
242,468
-196,909
| -45% | -$3.8M |
|
2838
Crinetics Pharmaceuticals
CRNX
$8.87B
| $5.18M | ﹤0.01% |
236,160
+203,201
| +617% | +$4.11M |
|
2839
Barings BDC
BBDC
$880M
| $5.18M | ﹤0.01% |
501,268
+339,882
| +211% | +$3.64M |
|
|
POND
2840
DELISTED
Angel Pond Holdings Corporation
POND
| $5.17M | ﹤0.01% |
524,310
+69,624
| +15% | +$683K |
|
|
SLVR
2841
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
| $5.17M | ﹤0.01% |
+535,600
| New | +$5.17M |
|
2842
Coca-Cola Femsa
KOF
$22.4B
| $5.17M | ﹤0.01% |
94,065
-8,781
| -9% | -$469K |
|
|
SRTA
2843
Strata Critical Medical Inc
SRTA
$470M
| $5.17M | ﹤0.01% |
+608,351
| New | +$4.27M |
|
2844
Kimbell Royalty Partners
KRP
$1.45B
| $5.16M | ﹤0.01% |
317,475
+304,058
| +2,266% | +$4.72M |
|
|
FIACU
2845
DELISTED
Focus Impact Acquisition Corp. Unit
FIACU
| $5.16M | ﹤0.01% |
515,000
-24,670
| -5% | -$248K |
|
2846
PUT
Dominion Energy
D
$60.2B
| $5.16M | ﹤0.01% |
60,700
+42,300
| +230% | +$3.4M |
|
2847
Workhorse Group
WKHS
$33.6M
| $5.15M | ﹤0.01% |
344
+285
| +483% | +$3.14M |
|
2848
Principal Financial Group
PFG
$24.6B
| $5.15M | ﹤0.01% |
70,163
-11,859
| -14% | -$859K |
|
2849
iShares Global Financials ETF
IXG
$682M
| $5.15M | ﹤0.01% |
+64,780
| New | +$5.23M |
|
2850
Ares Capital
ARCC
$13.8B
| $5.14M | ﹤0.01% |
245,471
+110,414
| +82% | +$2.35M |
|
Similar funds
Millennium Management's Q1 2022 Portfolio in Review
As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Millennium Management's Q1 2022 filing shows 1,492 new, 2,451 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
- Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.